浮针联合穴位贴敷对周围性面瘫病人疗效、面部残疾指数量表评分及抑郁自评量表评分的影响

目的 探究浮针联合穴位贴敷对周围性面瘫病人疗效、面部残疾指数量表评分及抑郁自评量表(SDS)评分的影响.方法 选取2015年3月至2017年6月收入湖南中医药高等专科学校附属第一医院治疗的周围性面瘫病人100例,以随机数字表法将其分为对照组(50例)和研究组(50例).对照组采用穴位贴敷法治疗,1次/天,贴敷6小时/次;研究组基于对照组基础上采用浮针法治疗,每隔两天1次,3次/周.均持续治疗1个月.通过面神经功能(HB)分级量表用于判定面瘫严重程度;通过面部残疾指数(FID)量表用于治疗前后治疗效果评价;通过焦虑自评量表(SAS)对病人焦虑症状进行评分;通过SDS对病人抑郁症状进行评分;通过匹兹堡睡眠质量指数(PSQI)对周围性面瘫病人治疗前后的睡眠质量状况进行评分.结果 治疗后,研究组周围性面瘫病人总有效率为98.00％,明显高于对照组的84.00％(P<0.05).治疗前,研究组和对照组周围性面瘫病人FDIP评分(16.02±2.94)分比(15.65±2.32)分]、FDIS评分(24.11±3.31)分比(24.63±2.86)分]、SDS评分(53.57±19.97)分比(53.62±21.68)分]比较,差异无统计学意义(P>0.05);治疗后,研究组FDIP评分、FDIS评分分别为(31.38±3.42)分和(35.96±3.68)分,均明显高于治疗前,且高于对照组的(24.45±3.05)分和(30.76±3.12)分;SDS评分为(26.73±8.96)分,显著低于治疗前,且低于对照组的(38.15±10.58)分(P<0.05).治疗前,两组周围性面瘫病人HB分级、SAS评分及PSQI评分比较,差异无统计学意义(P>0.05);治疗后,研究组HB分级、SAS评分、PSQI评分均显著低于治疗前,研究组低于对照组(P<0.05).结论 浮针联合穴位贴敷可有效治疗周围性面瘫,改善周围性面瘫病人面部残疾症状,对缓解病人焦虑、紧张、抑郁等情绪有所帮助,具有一定推广价值.

Effects of floating-needle therapy combined with acupoint application on the efficacy, facial disability index scale score and SDS score of palsypatients with peripheral facial palsy

Objective To explore the effects of floating-needle therapy combined with acupoint application on the efficacy, facialdisability index scale score and SDS score of palsypatients with peripheral facial palsy. Methods A hundred patients with peripheralfacial palsy who were admitted to The First Affiliated Hospital of Hunan Traditional Chinese Medical College from March 2015 to June2017 were selected, and according to the random number table method, were assigned into control group (50 cases) and research group(50 cases). The control group was treated with acupoint application, once a day, six hours a time, lasting for one month; the researchgroup was treated additionally with floating-needle therapy, once every two days, three times a week, lasting for one month. The House-Brackmann (HB) scale was used to determine the severity of facial palsy, the facial disability index (FDI) scale was used to evaluate thetherapeutic effects before and after treatment, the self-rating anxiety scale (SAS) was used to evaluate the anxiety symptoms of patients, the self-rating depression scale (SDS) was used to score depressive symptoms, and the sleep quality of patients with peripheral facialpalsy before and after treatment was evaluated by Pittsburgh Sleep Quality Index (PSQI). Results After treatment, the total effectiverate of patients with peripheral facial palsy was 98.00% in the research group, significantly higher than 84.00% in the control group (P< 0.05). Before treatment, there were no significant differences in FDIP score (16.02±2.94) vs. (15.65±2.32)], FDIS score (24.11±3.31) vs. (24.63±2.86)], SDS score (53.57±19.97) vs. (53.62±21.68)] between the research group and the control group (P>0.05); after treatment, the scores of FDIP and FDIS in the research group were (31.38±3.42) and (35.96±3.68) respectively, which were significantlyhigher than those before treatment and those (24.45±3.05) and (30.76±3.12)] in the control group; the SDS score was (26.73±8.96),which was significantly lower than that before treatment and that (38.15±10.58)] in the control group (P<0.05). Before treatment, there were no significant differences in HB grade, SAS score and PSQI score between the two groups (P>0.05). After treatment, HB grade,SAS score and PSQI score were significantly lower than those before treatment, and they were lower in the research group than in the